Company Mission

Dojindo Molecular Technologies, Inc. is a leading U.S. based distributor of innovative assay kits and chemicals for life science research.We continuously prioritize our customers’ satisfaction by providing quality support and innovative products to expand the field of life science research and development.

Our company culture reflects the meaning behind the character “Jin” ( 仁 ) , which means to respect and care for others. As our company implements the mission above, the “Jin” spirit is always in the forefront of our thoughts.  

How we began

1996

As a subsidiary of Dojindo Laboratories in Japan, Dojindo Molecular Technologies, Inc. opened its doors in Gaithersburg, MD as the main facility for new product development. Products such as DNA Damage Quantification Kit, SOD Assay Kit-WST, Labeling Kits series were developed, providing ready-to-use assay kits for customers around the world.


2000

Dojindo Molecular Technologies, Inc. became an additional sales location, bringing Dojindo products to the hands of research professionals in the North American Region.


2008

We relocated to Rockville, MD to focus solely on the sales and marketing activities in North America. Our current location brings is in close proximity to the researchers at the National Institutes of Health (NIH), National Cancer Institutes (NCI), FDA, Johns Hopkins University.


We continue to offer Japanese quality customer support and innovative products to not only to the surrounding area, but to our customers in the U.S., Canada, and South America.

About Dojindo Laboratories

Dojindo Laboratories was founded by Professor Keihei Ueno, a well-known researcher in chelating chemistry. Dojindo Laboratories was the first Japanese company to commercialize EDTA (ethylenediamine tetraacetic acid) in 1951. Since then, Dojindo Laboratories has been producing reagents to support the progress of scientific research. Dojindo Laboratories’ mission is to develop innovative tools for life science research. Dojindo Laboratories strives to contribute to the improvement of quality of life through scientific findings and the development of new medicines.

COVID-19 Announcement

Due to rising concerns regarding the COVID-19 (Coronavirus 2019) outbreak, Dojindo Molecular Technologies, Inc will be taking the necessary steps to prioritize public health and safety.

Scroll to Top